Publicaciones - IR Sant Pau

Buscar

01/09/2024 Heterogeneity of comorbidities captured by European national severe asthma registries in SHARP CRC

Rink, S, Freeman, A, Bansal, AT, Bossios, A, Frankemoelle, B, Schleich, F, Sont, JK, Singh, M, Bieksiene, K, Bourdin, A, Canonica, GW, Csoma, Z, Gemicioglu, B, Grisle, I, Popovic, SG, Hromis, S, Korn, S, Kuna, P, Loureiro, C, Mihaltan, F, Porsbjerg, C, Ramos-Barbon, D, Renaud, L, Sergejeva, S, Ten Brinke, A, Yasinska, V, Zervas, E, Skrgat, S, Kurukulaaratchy, R. Heterogeneity of comorbidities captured by European national severe asthma registries in SHARP CRC. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA1763. PMID:. IF:21.000(Q1/1D).

01/09/2024 Initial data analysis of the SHARP CRC patient population reveals a large heterogeneity among European patients with severe asthma

Fouka, E, Bansal, AT, Jaun, F, Håkansson, KEJ, Bieksiene, K, Bourdin, A, Butler, M, Canonica, GW, Csoma, Z, Dahlén, B, Gemicioglu, B, Grisle, I, Heaney, L, Heffler, E, Hromis, S, Kuna, P, Leuppi, J, Louis, R, Oureiro, C, Lúoviksdóttir, D, Mihaltan, F, Popovic, SG, Ramos-Barbon, D, Sedlak, V, Sergejeva, S, Skrgat, S, Ten Brinke, A, Yasinska, V, Zervas, E, Schleich, F, Porsbjerg, C, Bossios, A. Initial data analysis of the SHARP CRC patient population reveals a large heterogeneity among European patients with severe asthma. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA4008. PMID:. IF:21.000(Q1/1D).

01/09/2024 European physician perspectives on multimorbidity in severe asthma: findings from SHARP CRC

Rink, S, Freeman, A, Bansal, AT, Bossios, A, Frankemölle, B, Schleich, F, Sont, JK, Singh, M, Bieksiene, K, Bourdin, A, Canonica, GW, Csoma, Z, Gemicioglu, B, Grisle, I, Popovic, SG, Hromis, S, Korn, S, Kuna, P, Loureiro, C, Mihaltan, F, Porsbjerg, C, Ramos-Barbon, D, Renaud, L, Sergejeva, S, Ten Brinke, A, Yasinska, V, Zervas, E, Skrgat, S, Kurukulaaratchy, R. European physician perspectives on multimorbidity in severe asthma: findings from SHARP CRC. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA2149. PMID:. IF:21.000(Q1/1D).

01/09/2024 Clinical characteristics of severe asthma patients in Europe, according to the percentage of GDP spent on healthcare- a SHARP-CRC study

Jaun, F, Bánsal, AT, Fouka, E, Hakansson, KEJ, Bieksiene, K, Bourdin, A, Butler, M, Canonica, GW, Csoma, Z, Dahlén, B, Gemicioglu, B, Grisle, I, Heaney, L, Heffler, E, Hromis, S, Kuna, P, Mihaltan, F, Leuppi, JD, Loureiro, C, Louis, R, Luoviksdóttir, D, Ramos-Barbon, D, Popovic, SG, Samitas, K, Sedlak, V, Sergejeva, S, Skrat, S, Ten Brinke, A, Yasinska, V, Zervas, E, Schleich, F, Porsbjerg, C, Bossios, A. Clinical characteristics of severe asthma patients in Europe, according to the percentage of GDP spent on healthcare- a SHARP-CRC study. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA1248. PMID:. IF:21.000(Q1/1D).

01/09/2024 The SHARP CRC Health Economics Study. Simulation of the preventable costs of oral corticosteroids in severe asthmatics in eleven European countries

Bourdin, A, Bansal, AT, Di Matteo, S, Giacomo, CM, Heaney, B, Ten Brinke, A, Csoma, Z, Dahlen, B, Djukanovic, R, Heaney, L, Kuna, P, Heffler, E, Louis, R, Porsbjerg, C, Ramos-Barbon, D, Skrgat, S, Paulsson, T, Mascialino, B. The SHARP CRC Health Economics Study. Simulation of the preventable costs of oral corticosteroids in severe asthmatics in eleven European countries. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA1176. PMID:. IF:21.000(Q1/1D).

01/09/2024 Stoma Stent in a traqueotomy decanulation process. Experience in a cohort of patients with prolongued mechanical ventilation

Otero, ARP, Pujal, P, Rafecas, A, Panadero, C, Penacoba, P, Puy, C, Segura, M, Anton, PA. Stoma Stent in a traqueotomy decanulation process. Experience in a cohort of patients with prolongued mechanical ventilation. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA2615. PMID:. IF:21.000(Q1/1D).

01/09/2024 Real-world effectiveness of switching to Benralizumab in patients with severe asthma in the Catalan population. Catalan Society of Pulmonology (SOCAP) Registry

Arismendi, E, Muñoz, M, Crespo, A, Ausin, P, Castillo, JA, Curto, E, Lapuente, A, Arguedas, AM, Martínez-Rivera, C, Monserrate, D, Muñoz, X, Ojanguren, I, Palones, E, Paredes, M, Pilia, F, Picado, C, Sabater, G, Sabadell, C, Sogo, A, Cañete, C. Real-world effectiveness of switching to Benralizumab in patients with severe asthma in the Catalan population. Catalan Society of Pulmonology (SOCAP) Registry. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA3926. PMID:. IF:21.000(Q1/1D).

01/09/2024 Molecular insights into hypoxic burden physiopathology in OSA: a proteomic perspective

Pinilla, L, Dodani, K, Benitez, I, Esmaeli, N, Gracia-Lavedán, E, Torres, G, Minguez, O, Martinez, D, Martínez-García, MA, Abad, J, Masdeu, MJ, Mediano, O, Muñoz, C, Cabriada, V, Duran-Cantolla, J, Mayos, M, Coloma, R, Montserrat, JM, De la Peña, M, Cano-Pumarega, I, Barbé, F, Azarbarzin, A, Sanchez-De-la-Torre, M. Molecular insights into hypoxic burden physiopathology in OSA: a proteomic perspective. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA2693. PMID:. IF:21.000(Q1/1D).

01/09/2024 Improvement in lung function after six months of treatment with extrafine formulation single-inhaler triple therapy (efSITT) in patients with asthma-TriMaximize Study

Gessner, C, Bogoevska, V, Nachtigall, D, Russell, R, Ulrik, CS, Pohl, W, Plaza, V, Bourdin, A, Criée, CP, Trinkmann, F. Improvement in lung function after six months of treatment with extrafine formulation single-inhaler triple therapy (efSITT) in patients with asthma-TriMaximize Study. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA2121. PMID:. IF:21.000(Q1/1D).

01/09/2024 Impact of extrafine formulation single-inhaler triple therapy on asthma control and treatment adherence after six months of treatment in patients with asthma-TriMaximize study

Greulich, T, Bogoevska, V, Nachtigall, D, Russell, R, Suppli, C, Wolfgang, U, Pohl, W, Plaza, V, Bourdin, A, Baumeister, S, Gessner, C. Impact of extrafine formulation single-inhaler triple therapy on asthma control and treatment adherence after six months of treatment in patients with asthma-TriMaximize study. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA3907. PMID:. IF:21.000(Q1/1D).

01/08/2024 Spanish Consensus on Remission in Asthma (REMAS)

Alvarez-Gutiérrez, FJ, Casas-Maldonado, F, Soto-Campos, G, Blanco-Aparicio, M, Delgado, J, Galo, AP, Quirce, S, Plaza, V. Spanish Consensus on Remission in Asthma (REMAS). ARCHIVOS DE BRONCONEUMOLOGIA. 2024; 60(8)DOI:10.1016/j.arbres.2024.04.002. PMID:38697903. IF:9.200(Q1/1D).

01/06/2024 Diagnostic Value of Krebs von den Lungen (KL-6) for Interstitial Lung Disease: A European Prospective Cohort

Millan-Billi, P, Castellví, I, Martinez-Martinez, L, Mariscal, A, Barril, S, D'Alessandro, M, Franquet, T, Castillo, D. Diagnostic Value of Krebs von den Lungen (KL-6) for Interstitial Lung Disease: A European Prospective Cohort. ARCHIVOS DE BRONCONEUMOLOGIA. 2024; 60(6)DOI:10.1016/j.arbres.2024.03.028. PMID:38644152. IF:9.200(Q1/1D).

01/06/2024 The impact of smoking on bronchiectasis and its comorbidities

de la Rosa-Carrillo, D, de Granda-Orive, JI, Cáceres, LD, Pereyra, FG, Moreno, BR, Martínez-Garcia, MA, Suárez-Cuartin, G. The impact of smoking on bronchiectasis and its comorbidities. Expert Review of Respiratory Medicine. 2024; 18(5)DOI:10.1080/17476348.2024.2369716. PMID:38888096. IF:2.700(Q2/5D).

01/06/2024 BASELINE CHARACTERISTICS OF PATIENTS WITH ASTHMA AND PRIOR ORAL SYSTEMIC CORTICOSTEROID USE INITIATING DUPILUMAB IN A REAL-WORLD REGISTRY (RAPID)

Lugogo, NL, Heffler, E, Plaza,, Hilberg, O, Xia, C, Nash, S, Pandit-Abid, N, Jacob-Nara, JA, Sacks, H, Rowe, PJ, Deniz, Y, Hardin, M, Reed, C, Soler, X. BASELINE CHARACTERISTICS OF PATIENTS WITH ASTHMA AND PRIOR ORAL SYSTEMIC CORTICOSTEROID USE INITIATING DUPILUMAB IN A REAL-WORLD REGISTRY (RAPID). VALUE IN HEALTH. 2024; 27(6)DOI:. PMID:. IF:6.000(Q1/1D).

01/05/2024 Unraveling the Enigma: Spain Takes a Pioneering Step With REPAIR in the World of Inhaled Antibiotics

de la Rosa-Carrillo, D, Miravitlles, M, Pomares, X, Martínez-García, MA. Unraveling the Enigma: Spain Takes a Pioneering Step With REPAIR in the World of Inhaled Antibiotics. ARCHIVOS DE BRONCONEUMOLOGIA. 2024; 60(5)DOI:10.1016/j.arbres.2024.01.007. PMID:38310073. IF:9.200(Q1/1D).

01/05/2024 Extrafine Formulation Single-inhaler Triple Therapy Improves Lung Function After Six Months of Treatment in Patients With Asthma: Trimaximize Study

Gessner, C, Bogoevska, V, Nachtigall, D, Russell, R, Ulrik, CS, Pohl, W, Plaza, V, Bourdin, A, Akyildiz, B, Trinkmann, F. Extrafine Formulation Single-inhaler Triple Therapy Improves Lung Function After Six Months of Treatment in Patients With Asthma: Trimaximize Study. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2024; 209DOI:. PMID:. IF:19.400(Q1/1D).

24/04/2024 Association between nailfold videocapillaroscopy findings and sKL-6 levels in patients with idiopathic inflammatory myopathies-related interstitial lung disease

Santos, CS, Tandaipan, JL, Castillo, D, Martínez, LM, Codes, H, Sainz, L, Magallares, B, Moya, P, Corominas, H, Alvarez, ED, Castellvi, I. Association between nailfold videocapillaroscopy findings and sKL-6 levels in patients with idiopathic inflammatory myopathies-related interstitial lung disease. RHEUMATOLOGY. 2024; 63DOI:10.1093/rheumatology/keae163.188. PMID:. IF:4.400(Q1/1D).

24/04/2024 The current practice in the diagnostic work-up of patients with hemoptysis of unknown etiology an international survey

Mondoni, M, Cefalo, J, Carlucci, P, Puci, M, Saderi, L, Degrassi, M, Fernandez, AT, Pajares, V, Bodtger, U, Sorino, C, Zagaria, MP, Solidoro, P, Centanni, S, Sotgiu, G. The current practice in the diagnostic work-up of patients with hemoptysis of unknown etiology an international survey. MINERVA MEDICA. 2024; DOI:10.23736/S0026-4806.24.09192-4. PMID:38695633. IF:4.700(Q/D).

02/02/2024 Utility of bronchoalveolar lavage for COVID-19: a perspective from the Dragon consortium

Tomassetti, S, Ciani, L, Luzzi, V, Gori, L, Trigiani, M, Giuntoli, L, Lavorini, F, Poletti, V, Ravaglia, C, Torrego, A, Maldonado, F, Lentz, R, Annunziato, F, Maggi, L, Rossolini, GM, Pollini, S, Para, O, Ciurleo, G, Casini, A, Rasero, L, Bartoloni, A, Spinicci, M, Munavvar, M, Gasparini, S, Comin, C, Cerinic, MM, Peired, A, Henket, M, Ernst, B, Louis, R, Corhay, JL, Nardi, C, Guiot, J. Utility of bronchoalveolar lavage for COVID-19: a perspective from the Dragon consortium. Frontiers in Medicine. 2024; 11DOI:10.3389/fmed.2024.1259570. PMID:38371516. IF:3.000(Q1/2D).

01/01/2024 Methodology Employed to Develop the Airway Mucus Secretion Test (T-SEC): A Questionnaire to Evaluate Airway Mucus Hypersecretion in Patients With Asthma

Palones E., García-Rivero J.L., Cisneros C., Almonacid-Sánchez C., Pérez-de Llano L., Plaza V., Crespo-Lessmann A.. Methodology Employed to Develop the Airway Mucus Secretion Test (T-SEC): A Questionnaire to Evaluate Airway Mucus Hypersecretion in Patients With Asthma. ARCHIVOS DE BRONCONEUMOLOGIA. 2024; 60(3)DOI:10.1016/j.arbres.2024.01.002. PMID:38290898. IF:9.200(Q1/1D).

01/01/2024 Archivos de Bronconeumologia 59 (2023) 63–65, (S0300289622004975), (10.1016/j.arbres.2022.07.011)

Palones E., Curto E., Pelegrí A., Arilla M., Solanes I., Crespo-Lessmann A.. Archivos de Bronconeumologia 59 (2023) 63–65, (S0300289622004975), (10.1016/j.arbres.2022.07.011). ARCHIVOS DE BRONCONEUMOLOGIA. 2024; 60(1)DOI:10.1016/j.arbres.2023.11.007. PMID:38040573. IF:9.200(Q1/1D).

01/01/2024 Comparison of Long-term Response and Remission to Omalizumab and Anti-IL-5/IL-5R Using Different Criteria in a Real-life Cohort of Severe Asthma Patients

Valverde-Monge M., Sánchez-Carrasco P., Betancor D., Barroso B., Rodrigo-Muñoz J.M., Mahillo-Fernández I., Arismendi E., Bobolea I., Cárdaba B., Cruz M.J., Del Pozo V., Domínguez-Ortega J., González-Barcala F.J., Olaguibel J.M., Luna-Porta J.A., Martínez-Rivera C., Mullol J., Muñoz X., Peleteiro-Pedraza L., Picado Valles C., Plaza V., Quirce S., Rial M.J., Soto-Retes L., Valero A., Sastre J.. Comparison of Long-term Response and Remission to Omalizumab and Anti-IL-5/IL-5R Using Different Criteria in a Real-life Cohort of Severe Asthma Patients. ARCHIVOS DE BRONCONEUMOLOGIA. 2024; 60(1)DOI:10.1016/j.arbres.2023.11.011. PMID:38042707. IF:9.200(Q1/1D).

01/01/2024 Prognostic factors of progressive fibrotic hypersensitivity pneumonitis: a large, retrospective, multicentre, observational cohort study

Cano-Jiménez, E, Gómez, AV, Segovia, EV, Barrenechea, MA, Torres, JS, Francesqui, J, Carroz, KP, Solis, AJS, Fernández, OA, González, ABL, Bordas-Martinez, J, Cesar, EC, Vilarnau, EB, Villegas, DC, Pardessus, AR, Fernández, CG, Moyano, MG, Gajate, AU, Hortas, AB, Molina-Molina, M. Prognostic factors of progressive fibrotic hypersensitivity pneumonitis: a large, retrospective, multicentre, observational cohort study. Erj Open Research. 2024; 10(1)DOI:10.1183/23120541.00405-2023. PMID:38410707. IF:4.000(Q1/2D).

01/01/2024 Ultrasound in the Study of Thoracic Diseases: Innovative Aspects

Romero, BR, Torrubiano, IV, Juan, JM, Frades, SH, Pallares, JP, Ruiz, VP, Pérez, AW, Ramos, HC, Viedma, EC. Ultrasound in the Study of Thoracic Diseases: Innovative Aspects. ARCHIVOS DE BRONCONEUMOLOGIA. 2024; 60(1)DOI:10.1016/j.arbres.2023.10.009. PMID:37996336. IF:9.200(Q1/1D).

01/01/2024 Impact of Applying the Global Lung Initiative Criteria for Airway Obstruction in GOLD Defined COPD Cohorts: The BODE and CHAIN Experience

de-Torres, JP, Casanova, C, Marín, JM, Cabrera, C, Marín, M, Ezponda, A, Cosio, BG, Martínez, C, Solanes, I, Fuster, A, Calle, M, Gotera, C, Feu-Collado, N, Marin, A, Alcaide, AB, Sangro, M, Bastarrika, G, Celli, BR. Impact of Applying the Global Lung Initiative Criteria for Airway Obstruction in GOLD Defined COPD Cohorts: The BODE and CHAIN Experience. ARCHIVOS DE BRONCONEUMOLOGIA. 2024; 60(1)DOI:10.1016/j.arbres.2023.10.002. PMID:37925245. IF:9.200(Q1/1D).

01/01/2024 Global Lung Initiative as Diagnostic Criteria in Asthma-COPD Overlap Syndrome: Prevalence and Disease Characterization in a Real-Life Asthma Cohort

Betancor, D, Otal, M, Olaguibel, JM, Rodrigo-Muñoz, JM, Puebla, MJA, Arismendi, E, Barranco, P, Barroso, B, Bobolea,, Cárdaba, B, Cruz, MJ, Curto, E, Del Pozo,, Domínguez-Ortega, J, González-Barcala, FJ, Luna-Porta, JA, Martínez-Rivera, C, Mullol, J, Muñoz, X, Picado, C, Plaza,, Quirce, S, Rial, MJ, Roibás-Veiga,, Soto-Retes, L, Valero, A, Valverde-Monge, M, Sastre, J. Global Lung Initiative as Diagnostic Criteria in Asthma-COPD Overlap Syndrome: Prevalence and Disease Characterization in a Real-Life Asthma Cohort. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY. 2024; 34(3)DOI:10.18176/jiaci.0966. PMID:38888581. IF:4.800(Q1/1D).

01/01/2024 Use of Triple Therapy in Asthma: The GEMAFORUM V Task Force

Plaza, V, Trigueros, JA, Carretero, JA, Arranz, IO, Chicote, JMV, Sánchez, CA, Tomás, JB, Serrano, CC, Juncal, LD, Domínguez-Ortega, J, Rivero, JF, Campos, JGS, Fernández, EM, Martinez, S, Lacomba, JM, Quirce, S. Use of Triple Therapy in Asthma: The GEMAFORUM V Task Force. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY. 2024; 34(4)DOI:10.18176/jiaci.0975. PMID:38334050. IF:4.800(Q1/1D).

18/12/2023 Bronchoalveolar cytokine profile differentiates Pulmonary Langerhans cell histiocytosis patients from other smoking-related interstitial lung diseases

Barril, S, Acebo, P, Millan-Billi, P, Luque, A, Sibila, O, Tarin, C, Tazi, A, Castillo, D, Hortelano, S. Bronchoalveolar cytokine profile differentiates Pulmonary Langerhans cell histiocytosis patients from other smoking-related interstitial lung diseases. RESPIRATORY RESEARCH. 2023; 24(1)DOI:10.1186/s12931-023-02622-z. PMID:38111019. IF:4.700(Q1/2D).

01/12/2023 Therapeutic Goals and Treatable Traits: Long-Term Trends in a Severe Asthma Population

Almonacid-Sánchez C., García-Cosío B., Trisán-Alonso A., Callejas-González F.J., Cisneros C., Martínez-Moragón E., Plaza Moral V., Vera E., Soto-Campos J.G., Martínez-Rivera C., Alcazar-Navarrete B., Urrutia Landa I., García-Rivero J.L., Padilla Galo A., Álvarez-Gutierrez F., Ramos-González J., Carretero-Gracia J.Á., Lluch I., Puente L., Andujar-Espinosa R., Pérez-de-Llano L.. Therapeutic Goals and Treatable Traits: Long-Term Trends in a Severe Asthma Population. ARCHIVOS DE BRONCONEUMOLOGIA. 2023; 59(12)DOI:10.1016/j.arbres.2023.08.017. PMID:37865605. IF:8.700(Q1/1D).

01/11/2023 Comprehensive Observational Study in a Large Cohort of Asthma Patients after Adding LAMA to ICS/LABA

Plaza, V, Domínguez-Ortega, J, Alsina, DGS, Lo Re, D, Sicras-Mainar, A. Comprehensive Observational Study in a Large Cohort of Asthma Patients after Adding LAMA to ICS/LABA. Pharmaceuticals. 2023; 16(11)DOI:10.3390/ph16111609. PMID:38004474. IF:4.300(Q1/2D).

01/01/2023 Pulmonary Complications Following Hematopoietic Stem Cell Transplantation: Radiological Considerations

Franquet T., Giménez A., Mazzini S.. Pulmonary Complications Following Hematopoietic Stem Cell Transplantation: Radiological Considerations. Applied Psychology Readings: Selected Papers From The Singapore Conference On Applied Psychology 2022. 2023; DOI:10.1007/978-3-031-28797-8_6. PMID:. IF:(Q/D).

01/01/2023 Persistent Respiratory Failure and Re-Admission in Patients with Chronic Obstructive Pulmonary Disease Following Hospitalization for COVID-19

Figueira-Gonçalves, JM, García-Bello, MA, Ramallo-Fariña, Y, Méndez, R, Campos, AL, González-Jiménez, P, Peces-Barba, G, Molina-Molina, M, España, PP, García, E, Domínguez-Pazos, SD, Clemente, MG, Panadero, C, de la Rosa-Carrillo, D, Sibila, O, Martínez-Pitarch, MD, Toledo-Pons, N, López-Ramirez, C, Almonte-Batista, W, Macías-Paredes, A, Redenes-Bonet, D, Pérez-Rodas, EN, Lázaro, J, Fernández, SQ, Cordovilla, R, Cano-Pumarega, I, Torres, A, Menendez, R. Persistent Respiratory Failure and Re-Admission in Patients with Chronic Obstructive Pulmonary Disease Following Hospitalization for COVID-19. International Journal of Chronic Obstructive Pulmonary Disease. 2023; 18DOI:10.2147/COPD.S428316. PMID:37955022. IF:2.700(Q2/5D).

01/01/2023 Reply to "Olfactory Function and Biologic Treatments: A Comment on Available Real-life Studies"

Barroso, B, Valverde-Monge, M, Alobid,, Olaguibel, J, Rial, M, Quirce, S, Arismendi, E, Barranco, P, Betancor, D, Bobolea,, Cardaba, B, Carmona, MC, Curto, E, Dominguez-Ortega, J, Gonzalez-Barcala, F, Martinez-Rivera, C, Mahillo-Fernandez,, Munoz, X, Picado, C, Plaza,, Munoz, JR, Retes, LS, Valero, A, Delpozo,, Mullol, J, Sastre, J. Reply to "Olfactory Function and Biologic Treatments: A Comment on Available Real-life Studies". JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY. 2023; 33(6)DOI:10.18176/jiaci.0953. PMID:38095497. IF:6.700(Q1/2D).

01/08/2022 Epidemiological trends of HIV/HCV coinfection in Spain, 2015-2019

Fanciulli, C, Berenguer, J, Busca, C, Vivancos, MJ, Tellez, MJ, Dominguez, L, Domingo, P, Navarro, J, Santos, J, Iribarren, JA, Morano, L, Artero, A, Moreno, J, Rivero-Roman, A, Santos, I, Giner, L, Arminanzas, C, Montero, M, Manzardo, C, Cifuentes, C, Garcia, C, Galindo, MJ, Ferrero, OL, Sanz, J, de la Fuente, B, Rodriguez, C, Gaspar, G, Perez, L, Losa, JE, Force, L, Veloso, S, Martinez-Alfaro, E, Jarrin, I, De Miguel, M, Garcia, JG. Epidemiological trends of HIV/HCV coinfection in Spain, 2015-2019. HIV MEDICINE. 2022; 23(7)DOI:10.1111/hiv.13229. PMID:35037379. IF:3.000(Q3/7D).

01/07/2022 HCV reinfection after HCV therapy among HIV/HCV-coinfected individuals in Europe

Amele, S, Sandri, AK, Rodger, A, Vandekerckhove, L, Benfield, T, Milinkovic, A, Duvivier, C, Stellbrink, HJ, Sambatakou, H, Chkhartishvili, N, Caldeira, L, Laguno, M, Domingo, P, Wandeler, G, Gisinger, M, Kuzovatova, E, Dragovic, G, Knysz, B, Matulionyte, R, Rockstroh, JK, Lundgren, JD, Mocroft, A, Peters, L. HCV reinfection after HCV therapy among HIV/HCV-coinfected individuals in Europe. HIV MEDICINE. 2022; 23(6)DOI:10.1111/hiv.13212. PMID:34882940. IF:3.000(Q3/7D).

01/07/2022 The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA study

Mocroft, A, Miro, JM, Wandeler, G, Llibre, JM, Boyd, A, van Bremen, K, Beniowski, M, Mikhalik, J, Cavassini, M, Maltez, F, Duvivier, C, Foppa, CU, Knysz, B, Bakowska, E, Kuzovatova, E, Domingo, P, Zagalo, A, Viard, JP, Degen, O, Milinkovic, A, Benfield, T, Peters, L. The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA study. HIV MEDICINE. 2022; 23(6)DOI:10.1111/hiv.13210. PMID:34889022. IF:3.000(Q3/7D).

01/02/2022 The endocrine role of brown adipose tissue: An update on actors and actions

Gavalda-Navarro, A, Villarroya, J, Cereijo, R, Giralt, M, Villarroya, F. The endocrine role of brown adipose tissue: An update on actors and actions. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS. 2022; 23(1)DOI:10.1007/s11154-021-09640-6. PMID:33712997. IF:8.200(Q1/1D).

12/01/2022 Biomarker candidates for progression and clinical management of COVID-19 associated pneumonia at time of admission

Calvet, J, Berenguer-Llergo, A, Gay, M, Massanella, M, Domingo, P, Llop, M, Sanchez-Jimenez, E, Arevalo, M, Carrillo, J, Albinana, N, Arauz-Garofalo, G, Orellana, C, Delgado, JF, Serrano, A, Llobell, A, Graell, E, Garcia-Manrique, M, Moreno, M, Galisteo, C, Casado, E, Navarro, N, Gomez, A, Garcia-Cirera, S, Rusinol, M, Costa, E, Clotet, B, Vilaseca, M, Blanco, J, Gratacos, J. Biomarker candidates for progression and clinical management of COVID-19 associated pneumonia at time of admission. Scientific Reports. 2022; 12(1)DOI:10.1038/s41598-021-04683-w. PMID:35022497. IF:4.600(Q2/4D).

15/11/2021 Pre-exposure prophylaxis with hydroxychloroquine for COVID-19: a double-blind, placebo-controlled randomized clinical trial

Grau-Pujol, B, Camprubi-Ferrer, D, Marti-Soler, H, Fernandez-Pardos, M, Carreras-Abad, C, Velasco-de Andres, M, Ferrer, E, Muelas-Fernandez, M, Jullien, S, Barilaro, G, Ajanovic, S, Vera, I, Moreno, L, Gonzalez-Redondo, E, Cortes-Serra, N, Roldan, M, Artes-de Arcos, A, Mur, I, Domingo, P, Garcia, F, Guinovart, C, Munoz, J. Pre-exposure prophylaxis with hydroxychloroquine for COVID-19: a double-blind, placebo-controlled randomized clinical trial. Trials. 2021; 22(1)DOI:10.1186/s13063-021-05758-9. PMID:34781981. IF:2.728(Q4/8D).

01/11/2021 Growth Differentiation Factor 15 (GDF-15): A Novel Biomarker Associated with Poorer Respiratory Function in COVID-19

Alserawan, L, Penacoba, P, Echevarria, SEO, Castillo, D, Ortiz, E, Martinez-Martinez, L, Naranjo, EM, Domingo, P, Castellvi, I, Juarez, C, Mariscal, A. Growth Differentiation Factor 15 (GDF-15): A Novel Biomarker Associated with Poorer Respiratory Function in COVID-19. Diagnostics. 2021; 11(11)DOI:10.3390/diagnostics11111998. PMID:34829345. IF:3.992(Q2/4D).